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A. Abstract 
N-Glycosyltransferase of Actinobacillus pleuropneumoniae (ApNGT) is 
an enzyme which performs N-linked glycosylation of proteins. Furthermore, 
ApNGT is a cytoplasmic glycosyltransferase with the ability to target 
heterologous proteins. This is important as it can establish precedent for 
promising glycoprotein biotechnology in-vitro (1). At 631 residues in length 
ApNGT mimics a triangular topology. It has two terminals and three 
domains, and its binding pocket lies between an AAD domain and two 
Rossmann-fold domains (2). ApNGT’s function is part of a growing body of 
protein glycosylation research (3). Residues His-277 and Gln-469 in the 
binding pocket are crucial for catalytic activity. It stabilizes the UDP-glucose 
and acceptor peptide in place and greatly influences the glycosylation site of 
the peptide (4). It is an effective post-translational modification enzyme with 
an ability to glycosylate complex proteins while also having relaxed sugar 
substrate specificity (5) (Reviewed in Ref 6). Yet, it greatly prefers UDP-
glucose in the cytoplasm, uses an inverting mechanism, and recognizes the 
NX(S/T) sequence of the acceptor peptide or protein, where X is any amino 
acid but not proline (7). ApNGT also has a relaxed-substrate specificity and 
so is useful for a variety of acceptor peptide substrates, for example, human 
erythropoietin (1). We propose in this particular review NGT’s ability to in-
vitro glycosylate the membrane protein g-Sarcoglycan. ApNGT allows for 
exploration of the structure and dynamics of glycosylated proteins. An 
 
 
Blair - 4 
appropriate protocol includes the combination of ApNGT, UDP-glucose, and 
g-Sarcoglycan to glycosylate the membrane protein. We can then perform 
NMR to identify structural, functional, and dynamic changes in the protein 
(8). This study will increase our understanding of how glycosylation affects 
the structure and dynamics of glycosylated proteins. It can also help with the 
diagnostics of various glycoprotein abnormalities.  
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B. Introduction 
Glycosylation is a highly conserved process and has close involvement 
with protein function (2). Given its broad importance, it is critical to further our 
understanding of glycosylation: how it alters the function of a myriad of proteins 
(1). Studies in the recent past have approached glycosylation with experiments 
consisting of the basic reaction requirements. These requirements involve a 
glycosyltransferase, an acceptor peptide/substrate, and a hexose sugar such as 
UDP-glucose (6). Indeed, more complex synthesis of proteins have been 
demonstrated, combining various kinds of glycosyltransferases to extend a sugar 
scaffold on a protein, for example, polypeptide C34, a potent HIV inhibitor (5). 
However, there is little knowledge concerning how glycosylation affects 
membrane protein structure and dynamics, and further less how it alters the 
membrane proteins’ function (7). Even when larger proteins are studied in-vitro, 
it is hard to determine precise measurements from NMR spectra (8).  
In answer to this problem, we have developed a reliable experiment which 
reduces heterogeneity and can provide a more resolved NMR spectrum of a 
glycosylated membrane protein, g-Sarcoglycan. While this methodology will be 
reported in a later study, our aim is to discuss the characteristics and role of 
ApNGT (7). The importance of this methodology translates into a novel 
understanding of membrane proteins, many whose altered function leads to 
degenerative or cancerous diseases.   
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C. ApNGT Characteristics 
1. Gene localization and organization 
The amino acid sequence for NGT in Actinobacillus pleuropneumoniae 
(ApNGT) is 631 residues long. It shares similar gene localization of HMW1C 
from Haemophilus influenza, the ortholog of ApHMW1C*. The gene hmw1C 
encodes for the glycosyltransferase (HMW1C) which performs HMW1 
adhesin glycosylation. The gene hmw1C is accessory to hmw1A, the gene for 
the assembly of the HMW1 adhesin (2).  
Recent studies indicate the high amino acid sequence similarity (85%) 
of the two proteins HMW1C and ApHMW1C. Though similar in their 
primary structures, hmw1C is clustered around HMW1C adhesin assembly 
and secretion genes. This cluster of genes creates a two-partner secretion 
system which synthesizes and protects the HMW1 adhesin. HMW1C 
glycosylates several residues of the HMW1 adhesin to protect it from host 
degradation (2).  
Similarly, the gene organization of ApHMW1C† suggests its 
involvement in n-glycosyltransferase activity with post-translational 
modification of asparagine sites of HMW1 (10). The gene for ApHMW1C is 
positioned near open-reading frames of other glycosyltransferases, like 
glycosyl transferase, ribosomal protein RimO, and a nucleosidase (9).  
*synonymous with ApNGT 
†GenBank: ABN74719.1 (2010, The Actinobacillus) 
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Thus, ApHMW1C, now known as ApNGT, is distinct from its ortholog 
by its position in the bacterial genome, as HMW1C is positioned in a locus 
constituting a two-partner secretion (TPS) system (10). 
 
2. Protein Structure 
The structure of ApNGT contains three domains. The structure was 
first determined in 2011, showing it was a medium sized protein (~70kD) 
containing an N and C terminus, a catalytic site, and a narrow gap for the 
acceptor protein (2)(10). It has a triangular face, viewed from the side, formed 
by the AAD fold at the “top” and GT-A and GT-B folds on the “bottom.” Its 
three-dimensional crystal structure can be found with the PDB ID of 3Q3H 
(2) (Fig. 1). The protein, as all proteins are, is divided into two termini with 
secondary structures. The N-terminal contains an all-alpha domain (AAD) of 
thirteen repeating alpha helices. Together, the AAD forms the “head” of the 
enzyme, above the catalytic site in relation to the C-terminal end. The C-
terminal contains a GT-B fold, encompassing two domains, named GT-1 and 
GT-2, which have secondary structures similar to Rossmann-folds, 
alternation of alpha-helices and beta-sheets (2) (Fig. 2). Together the GT-1 
and GT-2 folds are similar in secondary structure and form the “bottom” of 
the enzyme. Nestled within the GT-2 domain is the binding site. Together, 
ApNGT is a glycosyltransferase whose GT-B domains characterizes its 
catalytic activity. 
 
 
Blair - 8 
The GT-B fold is metal-ion independent and characteristic of the GT-
41 family (10). The GT-B fold differs from the GT-A fold in two ways. The GT-
A fold glycosyltransferases use metal-ion dependent catalysis (Manganese is 
typically observed) and have a conserved DXD* motif, which helps with sugar 
binding in their binding site. In contrast, GT-B folds are metal-ion 
independent and do not have a conserved DXD motif. GT-A folds have one 
similar domain which contains Rossmann-folds, in contrast to the GT-B fold 
which has two similar domains. Yet, both GT-A and GT-B 
glycosyltransferases contain Rossmann-folds and sugar binding sites near 
these Rossmann-folds (Reviewed in Ref 11). These variations in the folds 
constitute the diversity of glycosyltransferases, and this further explains the 
nature of the binding site. 
The binding site is characterized by a narrow hole near the center of 
ApNGT. The interface between the GT-2 and AAD domains create a narrow 
groove adjacent to the binding site, whose length end is 7 angstroms and 
wide end is 18 angstroms. This is just large enough for proper alignment of 
UDP-hexose in the binding site. Conserved hydrophobic residues of both the 
AAD and GT-2 domain line this narrow groove, essential for retaining the 
acceptor peptide or protein and UDP-hexose. The proximity of the AAD and 
GT-B domain suggests its originality and influence on the catalytic site (2). 
In ApNGT, the singular catalytic site resides in an interdomain 
between the GT-1 and GT-2 domain, spatially more interactive with the GT-2 
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domain. During the binding of a UDP-hexose, two configurations are possible. 
These configurations induce small, local conformational changes (hydrophobic 
and Van der Waals) around the binding site to allow appropriate binding of 
the UDP-hexose. Site-directed mutagenesis supported the importance of 
certain binding site residues and the narrow groove for catalytic activity (2). 
There was almost no catalytic activity when the well conserved Lys-441, Asn-
521, and Asp-525 were deleted (2)(6)(Fig. 3 – 5). These amino acids affect 
binding the most, because they interact with the ribose and phosphate 
moieties of the UDP-hexose (12) (13). Lys-441, Asn-521, and Asp-525 interact 
with the two phosphate groups of UDP-hexose, stabilizing it through 
hydrogen-bonding and resolving hydrostatic clashes (2). Though the catalytic 
site is where glycosylation occurs, equally important is the site which holds 
the acceptor protein during catalysis. The site which accepts the UDP-hexose 
and acceptor protein is the AAD fold and the GT-1 domain of the GT-B fold. 
Thus, the catalytic site of ApNGT is suited in such a way for appropriate 
binding of the hexose moiety of UDP-hexose to the asparagine of the acceptor 
peptide or protein.  
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3. Post Translational Modifications 
ApNGT is a post-translational modification enzyme which performs N-
linked glycosylation. N-linked glycosylation is the attachment of a sugar 
moiety onto an asparagine residue of an acceptor protein (Reviewed in Ref 
3)(12)(13). The consensus sequence for ApNGT is NX(S/T) (on the acceptor 
protein), where X is any amino acid but proline (7). The attachment takes 
place through a bond between the nitrogen atom of the asparagine amide 
group and the anomeric carbon of the hexose sugar. Glycosyltransferases 
assemble hexose sugars onto proteins to form glycans, a complex of both 
sugar and protein. These hexose sugars may undergo sequential elongation 
by other glycosyltransferases such as alpha-6-glucosyltransferase (4)(7). With 
elongated sugar scaffolds, future studies can address how this affects the 
structure and function of proteins. This constitutes a promising exploration 
for glycoengineering. Glycosyltransferases are found in all three domains of 
life, but N-linked glycosylation is most prevalent in eukaryotes (14) (15). Half 
of all known eukaryotic proteins are modified by N-linked glycosylation (16). 
Glycosylation of proteins is involved in cell to cell signaling, signal 
transduction, protein folding, and interactions with viruses, to name a few 
(17)(18)(19). Thus, the study of ApNGT provides a way into the study of 
glycan structure and dynamics and how it might play a role in these 
functions. 
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4. Protein Function and Activity 
a. Background 
ApNGT catalyzes the transfer of a hexose-sugar from a 
nucleoside-sugar toward an asparagine site in an acceptor protein to 
form a protein (7). The discovery of ApNGT’s subfamily (of GT41) 
activity came through mass spectrometry of glycosylated HMW1 
adhesins. HMW1C was found to attach, through N-linked 
glycosylation, hexose sugars onto thirty-one asparagine sites in the 
HMW1 adhesin. The HMW1 adhesin is a pathogenic factor whose 
glycosylated surface protects it from premature degradation. The 
attachment of sugars onto glycans was novel at the time, as most 
proteins were thought to have been modified through N-acetylation. 
Determining the structure for HMW1C has been difficult through 
NMR, because of its size. Thus, a homolog of HMW1C was found in 
Actinobacillus pleuropneumoniae (20). This enzyme differs from known 
glycosyltransferase activity in the periplasm of prokaryotes called O-
OST modified glycosylation (21) (3). Biomolecular fluorescence 
complementation studies determined that NGT’s form both homo and 
heterodimers in live cells, localize in the Golgi apparatus, and attach 
N-glycans through post-translational modification (22). In addition, a 
lipid core is not needed as part of the hexose substrate, as seen in most 
bacterial N-glycan and LPS biosynthesis (21) (3). Bacterial N-glycan 
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biosynthesis and glycan biosynthesis in the endoplasmic reticulum is 
performed through en bloc glycosylation, which uses a lipid-linked 
oligosaccharide (3). ApNGT, in contrast, uses sequential glycosylation 
of sugars onto proteins in the cytoplasm (1)(3). This uncomplicated 
homolog of HMW1C, then, can be applied to glycosylation studies, 
having less requirements for the enzyme (1)(4). 
 
b. Substrates 
The homolog of HMW1C, known as ApNGT, glycosylates 
proteins with the hexose sugar substrates of glucose and galactose to 
Asn sites in acceptor proteins (10). ApNGT highly favors UDP-glucose 
as a substrate donor (Fig. 6) (10) (6). This is important because UDP-
glucose is fairly inexpensive. In addition, it prefers monosaccharides 
like UDP-galactose, UDP-xylose, and GDP-glucose (surprisingly) but 
not polysaccharides such as UDP-mannose (Fig. 7) (21) (6) (5). The 
advantage of using monosaccharides is noise reduction in NMR spectra 
when determining the structural changes as a result of glycosylation. 
It also has relaxed specificity for substrate peptides and can 
glycosylate heterologous proteins (1). This is important because these 
types of proteins are highly prevalent in pathways pertinent to 
membrane dynamic studies and abnormalities such as cancers and 
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diseases. The relaxed peptide sequence specificity and preference of 
UDP-glucose characterizes ApNGT’s utility for in-vitro assays. 
 
c. Mechanism and Kinetics 
During attachment of the sugar onto the acceptor protein or 
peptide, ApNGT uses an inverting mechanism and recognizes the 
NX(S/T) sequence of the acceptor protein. This sequence provides a 
reliable sequon for targeting proteins. ApNGT catalyzes the beta-
configuration of the bond between carbon one of glucose and the amide 
nitrogen of asparagine, as determined by NMR (7)(Figure 8). ApNGT 
highly prefers UDP-Glucose (5). The NX(S/T) sequon has the highest 
rate of turnover with UDP-Glucose as the substrate (kcat/Km = 502.8 M-
1s-1), and prefers threonine over serine of the acceptor sequence by a 
factor of ten (6). Basic residues which surround the pocket do not affect 
the kinetics, for when they were mutated to alanine there was no 
change in catalytic activity (6). ApNGT can be inhibited by epoxy-
peptide derivatives such as 2,3-epoxypropylglycine and 
epoxyethylglycine (23). These derivatives induce the enzyme to 
catalyze its own inactivation only when glycosylation occurs. Overall, 
ApNGT has the favorable trait of a fast turnover of UDP-glucose for n-
glycosylation.  
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d. Application 
ApNGT exhibits these characteristics stated above in the 
cytoplasm of E. coli (1). This is important for vaccine or diagnostic 
purposes, as its functional transfer into E. coli makes available a 
reliable experimental system (1). However, ApNGT has a relaxed 
substrate specificity, which is problematic in studying specific sites on 
glycosylated proteins. Yet, In addition, ApNGT cannot build complex 
sugar scaffolds, limited to glycosylation of one asparagine residue 
(6)(7). Yet these limitations are not significant overall, as it serves as 
an efficient enzyme for rapid glycosylation of desired proteins in-vitro 
(5)(7). This has already been demonstrated on various proteins and 
synthetic peptides (1). Some examples of modified proteins include: 
virus envelope glycoprotein, ribosome inactivating protein, 
hemagglutinin, and hydrolase inhibitor (24). In addition, both 
ApNGT’s cytoplasmic glycosylation role and role in virulence can be 
applied to glycoengineering, as stated previously (25). ApNGT 
glycosylated proteins can serve as primer sites for sugar scaffolding 
(Fig. 8) (7). ApNGT has successfully glycosylated several proteins of 
interest: Glyceraldehyde-3-phosphate dehydrogenase, 
Phosphoenolpyruvate carboxykinase, Cholera toxin subunit B (CtxB), 
human erythropoietin (1). Thus, ApNGT can be used with a variety of 
proteins and the full extent of its application is still unknown. 
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5. Relationship between Structure and Function 
The relationship between ApNGT’s structure and function is 
determined mainly by its binding core. As stated before, the turnover rate of 
ApNGT is affected by two crucial residues which affect substrate specificity: 
His-277 and Gln-469 (4). A mutant of ApNGT (Q469A), when Val, Ala, Ser, 
Leu, Phe, Gly were substituted at the Gln-469 site, had a higher turnover 
rate when assayed with the optimal peptide acceptor sequence ANVTK. Gln-
469 highly influences UDP-hexose, holding its position in the active site (4). 
His-272, His 277, Arg-281, Lys-441, and His-371 are basic amino acids 
located near but not necessarily needed for catalysis within the active site (6). 
The surface of the enzyme is electrostatically negative, with most 
hydrophobic residues forming alpha helices. The binding pocket is more 
electrostatically positive, as expected with basic residues such as histidine, 
lysine, and arginine. His-277 stabilizes the secondary phosphate of the UDP-
glucose, such that C1 of the glucose faces outward from the groove to where 
an Asparagine of the peptide may bind. Among other residues in the binding 
pocket, His-277, His-272, Arg-281, His-371, His-495, and Lys-441 all are 
highly conserved among other OGT, including H. sapiens OGT (6). 
Interestingly, though ApNGT has a separate mechanism than that of most 
OGT’s, both share the same substrate specificity (6). Perhaps the conserved, 
basic residues within the binding pocket indicate a conserved presence of 
stabilizing the UDP-glucose. It is still unclear how the mechanism of ApNGT 
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may occur, although His-277 and Gln-469 play a major role as said 
previously. In addition, the quaternary structure features surrounding the 
binding pocket allow for the proper positioning of the peptide, by hydrophobic 
interactions of alpha helices.  
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D. ApNGT and the in-vitro glycosylation of g-Sarcoglycan 
1. Description 
In-vitro glycosylation of proteins involves an acceptor peptide or 
protein, a sugar substrate, and a glycosyltransferase. Mass spectrometry and 
NMR studies can indicate the changes in dynamics and structure of the 
protein as a result of the attachment of these glycans (8). Its application is 
wide, as most proteins are glycosylated in post-translational modification. 
While recent studies have shown successful glycosylation of peptides in-vitro, 
none have been successful using membrane proteins. Few proteins have been 
glycosylated, and less still is our understanding of how glycosylation affects 
protein structure and activity. Structural determination of glycosylated 
proteins is hindered often by poor expression, diffraction, glycosylation, 
heterogeneity of the sample, and severe chemical shift overlap (8). Further 
still, no successful attempts have been made to glycosylate a membrane 
protein in-vitro, which present their own set of problems.  
 
2. Proposal of the in-vitro Glycosylation of g-Sarcoglycan with ApNGT 
Our group has successfully glycosylated a membrane protein, g-
Sarcoglycan, in-vitro, with research to be published soon. Through mass 
spectrometry we were able to detect the mass shift differentials which 
demonstrates we have successfully glycosylated the protein. In addition, we 
are working to determine the structure of  g-Sarcoglycan through NMR 
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methods as used previously (8). We overcame specific difficulties of 
glycosylation related to the use of lipids and detergents, which could have 
affected the glycosylation of g-Sarcoglycan. Specifically, NGT was used 
because of the characteristics described previously. It was used mainly 
because of its size, preference of UDP-Glucose in-vitro, and selective 
preference for the acceptor sequon NX(S/T) (6). This process can be applied to 
many membrane proteins, opening up more possibilities in glycoengineering, 
for vaccination and disease detection methods (3)(1)(4)(5)(24)(25). 
Glycosylating g-Sarcoglycan may also serve as a model with which to further 
understand Duchene Muscular Dystrophy.  
 
E. Conclusion 
In total, ApNGT has a high potential in glycoengineering, favorable to 
a variety of further studies of human and prokaryotic proteins. With its 
relaxed substrate specificity, its strong preference for UDP-glucose, and 
relatively small size, it is an effective and versatile enzyme (1) (7). Further 
studies may involve determining: its catalytic mechanism, what conditions 
suppress or induce gene expression, and interaction with other glycosylation 
enzymes (1) (3) (4) (24) (25). Most importantly, ApNGT can be used effectively 
in novel in-vitro glycosylation studies involving a myriad of proteins.  
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F. Figures 
 
 
FIGURE 1 – (Reference number 2) 
A. A domain comparison map of ApHWM1C (ApNGT) and HMW1C 
B. A ribbon model illustrating the structure of ApHWM1C (ApNGT) 
C. A space fill model of ApNGT divided into AAD, GT-2, and GT-1 
 
 
 
Blair - 20 
 
 
FIGURE 2 – (Reference number 2) 
A. An alignment of the N-terminal domain AAD showing conservation among A. 
pleuropneumoniae (Ap), H. influenzae (Hi), Yersinia enterocolitica RcsC (Ye) 
and Escherichia coli EtpC. Identical alignment is shown in blue and 
conserved is light blue 
B. A topology map of the N-terminal domain - alpha helices are shown as 
cylinders, and the ribbon models illustrate the position of the alpha helical 
domain on ApHMW1C (ApNGT) and GST-2 
C. A topology map of the N-terminal domain and TPRs (gold) of XcOGT, and a 
superimposition of ApHMW1C (ApNGT) and XcOGT models. Note the 
difference between the N-terminal domains (AAD), shown in light gray, and 
the similarity of the TPRs, shown in gold 
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FIGURE 3 – (Reference number 2) 
A. Two conformations of UDP-glucose from two protomers are shown in the 
binding pocket, with essential residues (stick) indicated in bold black 
(ApHMW1C) and magenta (HMW1C). Water molecules in blue are shown, 
with black dashed lines indicating hydrogen bonding. 
 
 
 
FIGURE 4 – (Reference number 6) 
A crystal structure of ApNGT and UDP, with key residues highlighted in 
magenta, indicating a basic interaction of less than 8 angstroms from the ß-
phosphate of UDP.  
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FIGURE 5 – (Reference number 6)  
 
A genetic sequence map showing the conservation of catalytic residues His-
272, His-277, Arg-281, His-371, His-495, and K-441 among various 
glycosyltransferases. 
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FIGURE 6 – (Reference number 6) 
 
A graph showing the amount of UDP formation from the reaction of ApNGT 
and sugar substrates UDP-Glc, UDP-Gal, and UDP-GlcNAc.  
 
 
 
FIGURE 7 – (Reference number 6) 
 
A graph illustrating the glycolytic turnover rates of UDP-Glc, UDP-Xyl, UDP-
Gal, and GDP-Glc by ApNGT. Note the magnitude of the turnover rate values.  
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FIGURE 8 – (Reference number 7) 
 
 A picture showing the method by which glycan scaffolds are developed. The 
acceptor sequence N-X-S/T is the base upon which NGT and 𝛼6GlcT glycosylate 
UDP-hexose (blue circle) onto the Asn residue/previous hexoses.  
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